Omnicell (OMCL) Competitors $29.92 +0.23 (+0.77%) Closing price 10/15/2025 04:00 PM EasternExtended Trading$30.44 +0.52 (+1.75%) As of 10/15/2025 05:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OMCL vs. MASI, AMN, WST, HSTM, MDRX, CRTX, IRTC, HNGE, PRVA, and INSPShould you be buying Omnicell stock or one of its competitors? The main competitors of Omnicell include Masimo (MASI), AMN Healthcare Services (AMN), West Pharmaceutical Services (WST), HealthStream (HSTM), Veradigm (MDRX), Cortexyme (CRTX), iRhythm Technologies (IRTC), Hinge Health (HNGE), Privia Health Group (PRVA), and Inspire Medical Systems (INSP). Omnicell vs. Its Competitors Masimo AMN Healthcare Services West Pharmaceutical Services HealthStream Veradigm Cortexyme iRhythm Technologies Hinge Health Privia Health Group Inspire Medical Systems Omnicell (NASDAQ:OMCL) and Masimo (NASDAQ:MASI) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, media sentiment, profitability, valuation and dividends. Which has more volatility & risk, OMCL or MASI? Omnicell has a beta of 0.88, suggesting that its share price is 12% less volatile than the S&P 500. Comparatively, Masimo has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Which has preferable earnings & valuation, OMCL or MASI? Omnicell has higher earnings, but lower revenue than Masimo. Masimo is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOmnicell$1.11B1.24$12.53M$0.5059.84Masimo$2.09B3.85-$304.90M-$8.52-17.44 Do insiders and institutionals hold more shares of OMCL or MASI? 97.7% of Omnicell shares are owned by institutional investors. Comparatively, 86.0% of Masimo shares are owned by institutional investors. 2.5% of Omnicell shares are owned by company insiders. Comparatively, 9.7% of Masimo shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media favor OMCL or MASI? In the previous week, Masimo had 6 more articles in the media than Omnicell. MarketBeat recorded 9 mentions for Masimo and 3 mentions for Omnicell. Masimo's average media sentiment score of 0.76 beat Omnicell's score of 0.62 indicating that Masimo is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omnicell 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Masimo 2 Very Positive mention(s) 4 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer OMCL or MASI? Omnicell currently has a consensus target price of $46.71, suggesting a potential upside of 56.13%. Masimo has a consensus target price of $194.60, suggesting a potential upside of 30.99%. Given Omnicell's higher possible upside, analysts clearly believe Omnicell is more favorable than Masimo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Omnicell 1 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.38Masimo 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.75 Is OMCL or MASI more profitable? Omnicell has a net margin of 2.01% compared to Masimo's net margin of -24.85%. Masimo's return on equity of 26.54% beat Omnicell's return on equity.Company Net Margins Return on Equity Return on Assets Omnicell2.01% 4.27% 2.44% Masimo -24.85%26.54%11.49% SummaryMasimo beats Omnicell on 11 of the 17 factors compared between the two stocks. Get Omnicell News Delivered to You Automatically Sign up to receive the latest news and ratings for OMCL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OMCL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OMCL vs. The Competition Export to ExcelMetricOmnicellMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.36B$2.29B$6.11B$10.46BDividend YieldN/AN/A5.73%4.77%P/E Ratio59.8441.4785.3627.36Price / Sales1.2413.54605.35135.57Price / Cash9.7062.9837.4661.86Price / Book1.1112.8412.436.81Net Income$12.53M-$65.79M$3.32B$276.80M7 Day Performance-3.86%1.52%0.58%0.42%1 Month Performance-7.43%15.04%10.53%7.86%1 Year Performance-29.70%38.87%72.99%41.24% Omnicell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OMCLOmnicell3.681 of 5 stars$29.92+0.8%$46.71+56.1%-29.4%$1.36B$1.11B59.843,670MASIMasimo4.3548 of 5 stars$148.13+0.6%$194.60+31.4%+3.2%$8.00B$2.09B26.935,600Analyst UpgradeAMNAMN Healthcare Services4.0107 of 5 stars$19.83-3.4%$23.25+17.2%-49.3%$786.80M$2.98B9.732,968Analyst ForecastWSTWest Pharmaceutical Services4.8746 of 5 stars$268.21-1.6%$321.89+20.0%-9.5%$19.60B$2.89B39.1610,600Positive NewsUpcoming EarningsAnalyst ForecastHSTMHealthStream4.729 of 5 stars$27.34-0.1%$31.00+13.4%-9.8%$810.98M$291.65M40.841,093Upcoming EarningsMDRXVeradigm2.7509 of 5 stars$4.70flat$13.00+176.6%-48.9%$508.85M$1.53B0.008,000CRTXCortexymeN/A$1.65+0.6%N/A+151.0%$49.75MN/A-0.5655IRTCiRhythm Technologies1.4907 of 5 stars$175.74+0.1%$172.17-2.0%+192.2%$5.64B$591.84M0.002,000Analyst ForecastHNGEHinge HealthN/A$51.90+1.2%$57.13+10.1%N/A$4.02BN/A0.001,514PRVAPrivia Health Group3.5077 of 5 stars$24.13+0.2%$28.58+18.5%+43.2%$2.96B$1.74B219.001,140INSPInspire Medical Systems4.9158 of 5 stars$76.36-0.3%$154.43+102.2%-60.3%$2.26B$802.80M33.301,246Analyst ForecastAnalyst Revision Related Companies and Tools Related Companies Masimo Competitors AMN Healthcare Services Competitors West Pharmaceutical Services Competitors HealthStream Competitors Veradigm Competitors Cortexyme Competitors iRhythm Technologies Competitors Hinge Health Competitors Privia Health Group Competitors Inspire Medical Systems Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OMCL) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredBuy this stock before Tesla’s November 6 announcementThe End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omnicell, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omnicell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
